Scienture Holdings (SCNX)
NASDAQ:SCNX
Want to see SCNX full AI Analyst Report?
SCNX Stock Chart & Stats
$0.55
-$0.13(-2.47%)
At close: 4:00 PM EST
$0.55
-$0.13(-2.47%)
Day’s Range― - ―
52-Week Range$0.24 - $2.60
Previous CloseN/A
Volume1.53K
Average Volume (3M)4.08M
Market Cap
$17.26M
Enterprise Value-$6.63B
Total Cash (Recent Filing)$6.66B
Total Debt (Recent Filing)$24.14M
Price to Earnings (P/E)―
Beta3.36
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding40,630,814
10 Day Avg. Volume11,411,402
30 Day Avg. Volume4,082,790
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)<0.01
Price to Sales (P/S)181.35
P/FCF Ratio>-0.01
Enterprise Value/Market Cap-384.13
Enterprise Value/Revenue-15.37K
Enterprise Value/Gross Profit-20.98K
Enterprise Value/Ebitda170.34
Forecast
1Y Price Target
$1.50Price Target Upside172.73% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Manageable LeverageRecent reporting shows debt is low relative to equity on a TTM basis, which reduces near-term refinancing pressure and interest burden. That improved leverage gives the company more flexibility to support commercialization and R&D spending over the next several months versus prior, more volatile capital structures.
High Gross Margin PotentialManagement has demonstrated the ability to achieve very high gross margins on recent TTM revenue, indicating strong unit economics or favorable pricing for core offerings. If SG&A discipline follows, these durable product-level margins could underpin sustainable profitability as revenues scale.
Provides Committed Financing RunwayThe $11.42M structured financing is a material, secured infusion earmarked for working capital and commercialization. This extends operational runway and funds product development and go-to-market activities, increasing the chance management can execute on commercialization initiatives over the coming 2–6 months.
Bears Say
Persistent Cash BurnOperating and free cash flow remain deeply negative on a TTM basis, indicating the business cannot self-fund growth or operations. Persistent cash burn raises reliance on external financing, risks dilution or restrictive financings, and limits the company's ability to invest sustainably in commercialization.
Loss-making And Volatile EarningsThe company's earnings profile is unstable with large net losses and deeply negative operating margins. Historical revenue volatility and inconsistent profitability hinder predictable cash generation, impair long-term reinvestment capacity, and increase execution risk for turning high gross margins into sustained net profitability.
Restrictive Financing Covenants & TriggersThe secured notes include broad security interests, strict reporting and structural covenants, and Major/Minor Triggers that can accelerate repayment or raise balances/interest up to 25%. These terms constrain capital-structure flexibility, raise default risk, and could force costly remedies that impair long-term execution.
Scienture Holdings News
SCNX FAQ
What was Scienture Holdings’s price range in the past 12 months?
Scienture Holdings lowest stock price was $0.24 and its highest was $2.60 in the past 12 months.
What is Scienture Holdings’s market cap?
Scienture Holdings’s market cap is $17.26M.
When is Scienture Holdings’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Scienture Holdings’s earnings last quarter?
Currently, no data Available
Is Scienture Holdings overvalued?
According to Wall Street analysts Scienture Holdings’s price is currently Undervalued.
Does Scienture Holdings pay dividends?
Scienture Holdings pays a Notavailable dividend of $1.5 which represents an annual dividend yield of N/A. See more information on Scienture Holdings dividends here
What is Scienture Holdings’s EPS estimate?
Scienture Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Scienture Holdings have?
Scienture Holdings has 40,630,814 shares outstanding.
What happened to Scienture Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Scienture Holdings?
Currently, no hedge funds are holding shares in SCNX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Scienture Holdings
TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.
SCNX Stock 12 Month Forecast
Average Price Target
$1.50
▲(172.73% Upside)
Technical Analysis
Ownership Overview
16.82% Insiders
1.70% Mutual Funds
<0.01% Other Institutional Investors
80.47% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---